This company has been marked as potentially delisted and may not be actively trading. Blueprint Medicines (BPMC) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock BPMC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Shareholder Alert: The Ademi Firm Continues to Investigate the Blueprint Medicines Corporation TransactionSeptember 15 at 2:10 AM | businesswire.comShareholder Alert: The Ademi Firm Investigates the Blueprint Medicines Corporation TransactionAugust 27, 2025 | businesswire.comBlueprint Medicines Corporation (NASDAQ:BPMC) Shares Bought by Cwm LLCJuly 25, 2025 | marketbeat.comBlueprint Medicines Corporation (NASDAQ:BPMC) Receives Average Recommendation of "Hold" from BrokeragesJuly 24, 2025 | marketbeat.comY Intercept Hong Kong Ltd Acquires New Position in Blueprint Medicines Corporation (NASDAQ:BPMC)July 23, 2025 | marketbeat.comCrestwood Advisors Group LLC Makes New Investment in Blueprint Medicines Corporation (NASDAQ:BPMC)July 23, 2025 | marketbeat.comJennison Associates LLC Lowers Holdings in Blueprint Medicines Corporation (NASDAQ:BPMC)July 20, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Upgraded by Wall Street Zen to "Hold" RatingJuly 19, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Reaches New 52-Week High - Here's WhyJuly 17, 2025 | marketbeat.comSegall Bryant & Hamill LLC Cuts Stock Position in Blueprint Medicines Corporation (NASDAQ:BPMC)July 17, 2025 | marketbeat.comBank of New York Mellon Corp Acquires 3,586 Shares of Blueprint Medicines Corporation (NASDAQ:BPMC)July 17, 2025 | marketbeat.com$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Blueprint Medicines Corporation (NASDAQ: BPMC)July 14, 2025 | globenewswire.comBlueprint Medicines Corporation (NASDAQ:BPMC) Stock Holdings Lowered by Emerald Advisers LLCJuly 13, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Cuts Stock Position in Blueprint Medicines Corporation (NASDAQ:BPMC)July 12, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Sees Strong Trading Volume - Here's WhyJuly 10, 2025 | marketbeat.comBlueprint Medicines Corporation (NASDAQ:BPMC) Shares Purchased by Brown Advisory Inc.July 9, 2025 | marketbeat.comInsider Selling: Blueprint Medicines Corporation (NASDAQ:BPMC) Insider Sells 1,051 Shares of StockJuly 9, 2025 | insidertrades.comWealth Enhancement Advisory Services LLC Invests $297,000 in Blueprint Medicines Corporation (NASDAQ:BPMC)July 9, 2025 | marketbeat.comBlueprint Medicines Corporation (NASDAQ:BPMC) Insider Sells $134,790.75 in StockJuly 8, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Reaches New 1-Year High - Here's What HappenedJuly 8, 2025 | marketbeat.comCalamos Advisors LLC Purchases New Shares in Blueprint Medicines Corporation (NASDAQ:BPMC)July 8, 2025 | marketbeat.comMoody Aldrich Partners LLC Takes $1.98 Million Position in Blueprint Medicines Corporation (NASDAQ:BPMC)July 4, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Hits New 52-Week High - Still a Buy?July 1, 2025 | marketbeat.comBPMC Blueprint Medicines Corporation - Seeking AlphaJuly 1, 2025 | seekingalpha.comPeregrine Capital Management LLC Sells 2,663 Shares of Blueprint Medicines Corporation (NASDAQ:BPMC)June 30, 2025 | marketbeat.comBlueprint Medicines Corporation (BPMC) - Yahoo FinanceJune 29, 2025 | finance.yahoo.comDiversified Trust Co Grows Position in Blueprint Medicines Corporation (NASDAQ:BPMC)June 29, 2025 | marketbeat.comBlueprint Medicines Corporation (NASDAQ:BPMC) Receives Average Recommendation of "Hold" from AnalystsJune 29, 2025 | marketbeat.comAMI Asset Management Corp Invests $970,000 in Blueprint Medicines Corporation (NASDAQ:BPMC)June 26, 2025 | marketbeat.comBlueprint Medicines Presents Strong Long-Term Data for AYVAKIT in Systemic MastocytosisJune 24, 2025 | msn.comBlueprint Medicines (NASDAQ:BPMC) Sees Strong Trading Volume - Here's What HappenedJune 24, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Hits New 1-Year High - Here's WhyJune 23, 2025 | marketbeat.comBLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint ...June 22, 2025 | morningstar.comMSG Americas Securities LLC Has $644,000 Position in Blueprint Medicines Corporation (NASDAQ:BPMC)June 22, 2025 | marketbeat.comBLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMCJune 20, 2025 | businesswire.comBlueprint Medicines (NASDAQ:BPMC) Earns Equal Weight Rating from Wells Fargo & CompanyJune 17, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Sees Large Volume Increase - Should You Buy?June 16, 2025 | marketbeat.comHAPPY FATHER'S DAY! and $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Blueprint Medicines Corporation (NASDAQ: BPMC)June 15, 2025 | globenewswire.comAssenagon Asset Management S.A. Reduces Position in Blueprint Medicines Co. (NASDAQ:BPMC)June 15, 2025 | marketbeat.comGAMMA Investing LLC Purchases 28,615 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)June 13, 2025 | marketbeat.comBlueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI CongressesJune 12, 2025 | prnewswire.comBlueprint Medicines (NASDAQ:BPMC) Reaches New 12-Month High - Should You Buy?June 11, 2025 | marketbeat.comBlueprint Medicines Co. (NASDAQ:BPMC) Stake Raised by Rhumbline AdvisersJune 11, 2025 | marketbeat.comBest Growth Stocks To Follow Now - June 9thJune 9, 2025 | marketbeat.comUBS Sticks to Its Hold Rating for Blueprint Medicines (BPMC)June 8, 2025 | theglobeandmail.comNBC Securities Inc. Purchases 2,646 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)June 8, 2025 | marketbeat.comGrowth Stocks To Follow Now - June 5thJune 5, 2025 | marketbeat.comMorgan Stanley Issues Positive Forecast for Blueprint Medicines (NASDAQ:BPMC) Stock PriceJune 5, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Given New $129.00 Price Target at UBS GroupJune 5, 2025 | marketbeat.comBlueprint Medicines (NASDAQ:BPMC) Stock Rating Lowered by GuggenheimJune 5, 2025 | marketbeat.com Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BPMC Media Mentions By Week BPMC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPMC News Sentiment▼0.000.92▲Average Medical News Sentiment BPMC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPMC Articles This Week▼18▲BPMC Articles Average Week Get the Latest News and Ratings for BPMC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Blueprint Medicines and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies INSM News Today BNTX News Today TEVA News Today SMMT News Today GMAB News Today ASND News Today VTRS News Today RDY News Today QGEN News Today BBIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPMC) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blueprint Medicines Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Blueprint Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
